COMP <GO>
PRCT vs TNDM // EV/EBITDA & P/E VALUATION
PROCEPT BioRobotics Corporation (NASDAQ) VS. Tandem Diabetes Care Inc. (NASDAQ) • 15-METRIC TALLY: PRCT 4
— TNDM 4
■ METRIC PARITY
LAST: $20.30 (+0.50%) • MKT CAP: $1.16B
valuation
—
LAST: $19.79 (+0.56%) • MKT CAP: $1.38B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRCT VS. TNDM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRCT | TNDM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 63.70% | 53.80% | +9.90 | PRCT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.02% | -2.15% | -2.87 | TNDM | /fcf-yield <GO> |
| Operating Margin | -33.70% | -18.50% | -15.20 | TNDM | /operating-margins <GO> |
| Net Profit Margin | 0.00% | -20.20% | +20.20 | PRCT | /net-margins <GO> |
| Revenue Growth (YoY) | 37.20% | 7.90% | +29.30 | PRCT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.98 | 0.20 | +3.78 | PRCT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.7 | 62.4 | -11.64 | TNDM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.16B | $1.38B | -$214.3M | TNDM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRCT REV | TNDM REV | PRCT GROSS % | TNDM GROSS % | PRCT FCF | TNDM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $308.1M | $1.01B | 63.7% | 53.8% | -$58.3M | -$29.7M |
| FY 2024 | $224.5M | $940.2M | 61.1% | 52.1% | -$103.6M | $5.0M |
| FY 2023 | $136.2M | $747.7M | — | — | -$108.0M | -$31.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRCT // BETA —
TNDM // BETA —